Expanding the Role of PARP Inhibitors: Emerging Strategies in BRCA+ and HRD+ Breast Cancer

Update: 2025-07-21

Description

In this episode, Dr. William Gradishar reviews key data on PARP inhibitors in breast cancer, including early insights from the OPERETTA and CompLEEment trials. He explores emerging combination strategies with immunotherapy and DNA-damaging agents, the potential to reduce chemotherapy use, and new tools to better identify candidates for targeted treatment.
Let us know what you thought of this week’s episode on Twitter: @physicianswkly
Want to share your medical expertise, research, or unique experience in medicine on the PW podcast? Email us at editorial@physweekly.com!
Thanks for listening!

Comments

In Channel

Combating Medical Misinformation, Part 2: Where Should Physicians Start?

2025-11-0513:29

Mastering Motions and Strategy in Medical Malpractice Cases

2025-10-3117:45

Combating Medical Misinformation, Part 1: Meeting Patients Where They Are Online

2025-10-2913:25

Post-Dobbs Laws Delay Medically Indicated Care for Pregnant Patients

2025-10-2210:25

Patients & Physicians Find Renewed Connection Through “Commit to Sit” Initiative

2025-10-1507:01

Navigating Vaccine Policy Shifts in Clinical Practice

2025-10-0833:38

Apologizing to Patients: Malpractice Attorney Shares How to Avoid Legal Risk

2025-10-0117:03

HER2+ Horizons: Episode 2: Sequencing After Progression‚ÄîWhat Comes Next?

2025-09-2409:59

Gynecologic Cancer Awareness Month: Guiding Patients Through Cervical Screening Choices

2025-09-2409:14

Building Health Literacy to Empower Patients & Improve Outcomes, Part 2

2025-09-1711:07

Building Health Literacy to Empower Patients & Improve Outcomes, Part 1

2025-09-1020:44

How the Eggshell Skull Doctrine Shapes Liability in Malpractice Cases

2025-09-0310:12

Digital Health Tools Offer New Window for COPD Exacerbation Prevention

2025-08-2711:21

SERENA-6 at ASCO 2025: ctDNA-Guided Therapy in HR+/HER2- mBC

2025-08-1325:50

How H. R. 1 Could Reshape Healthcare Access, Coverage, and Physician Payment

2025-08-1341:25

Patient Autonomy or Physician Liability? How to Navigate When Patients Dictate Care

2025-08-0614:45

Building a Healthcare Workforce That Stays, Part 2: Personalized Learning Approaches

2025-07-3014:03

Building a Healthcare Workforce That Stays, Part 1: Staffing & Simulation Training

2025-07-2310:36

Expanding the Role of PARP Inhibitors: Emerging Strategies in BRCA+ and HRD+ Breast Cancer

2025-07-2116:10

Tapping AI to Enhance Ablation Precision & Efficiency in Atrial Fibrillation

2025-07-1609:12

00:00

Expanding the Role of PARP Inhibitors: Emerging Strategies in BRCA+ and HRD+ Breast Cancer

#box-pro-ellipsis-176238213344236{-webkit-line-clamp:2;}Expanding the Role of PARP Inhibitors: Emerging Strategies in BRCA+ and HRD+ Breast Cancer

Expanding the Role of PARP Inhibitors: Emerging Strategies in BRCA+ and HRD+ Breast Cancer

Physician's Weekly

Expanding the Role of PARP Inhibitors: Emerging Strategies in BRCA+ and HRD+ Breast Cancer